# A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

> **NCT07223840** · PHASE2 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 222 (estimated)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Brenipatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07223840
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07223840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07223840, "A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07223840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*